cimetidine has been researched along with Dyspepsia in 58 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Dyspepsia: Impaired digestion, especially after eating.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare ecabet sodium and cimetidine in relieving symptoms of functional dyspepsia." | 9.12 | Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial. ( Choi, SR; Hahm, KB; Kim, JJ; Kim, N; Kim, SK; Lee, DH; Lee, EH; Lee, JH; Lee, ST; Park, JJ; Rhee, JC, 2006) |
| "Double-blind randomized controlled trials in single subjects (N of 1 RCTs) have demonstrated a beneficial symptomatic effect of cimetidine in reflux- or ulcer-like non-ulcer dyspepsia (NUD)." | 9.07 | Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. ( Dybdahl, J; Fosstvedt, D; Johannessen, T; Kleveland, PM; Kristensen, P; Løge, I; Petersen, H, 1992) |
| "Before endoscopy a double-blind, randomized, controlled, single-subject trial comparing the symptomatic effect of 1-day treatment periods with cimetidine and placebo was conducted in patients with dyspepsia." | 9.07 | The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials. ( Dybdahl, J; Fosstvedt, D; Johannessen, T; Kleveland, PM; Kristensen, P; Løge, I; Petersen, H, 1991) |
| "A randomized double-blind antacid-controlled study was carried out to investigate the speed of onset of relief from dyspeptic pain with a novel, chewable formulation of cimetidine in 80 patients with persistent dyspepsia." | 9.06 | Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief? ( Parr, SN, 1989) |
| "The effect of cimetidine and placebo was examined in 123 patients with non-ulcer dyspepsia (NUD) by means of a 12-day multi-crossover model with 5 regular interchanges between cimetidine and placebo." | 9.06 | Cimetidine responders in non-ulcer dyspepsia. ( Fjøsne, U; Hafstad, PE; Halvorsen, T; Johannessen, T; Kleveland, PM; Kristensen, P; Løge, I; Petersen, H; Sandbakken, P, 1988) |
| "A randomized double-blind, placebo-controlled study was carried out in 56 patients with essential dyspepsia to investigate the therapeutic efficacy of cimetidine in providing symptomatic relief." | 9.06 | Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study. ( Broor, SL; Kumar, A; Singal, AK, 1989) |
| "Patients with dyspepsia of unknown origin were randomly allocated to a controlled double-blind study to examine the symptomatic effect of cimetidine and antacid especially on the relief of pain, nausea, and bloating." | 9.06 | Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. ( Bodemar, G; Brodin, U; Gotthard, R; Jönsson, KA, 1988) |
| "Sixty patients with nonulcer dyspepsia took cimetidine 1 g daily or a placebo for 5 weeks in a double-blind trial." | 9.06 | A controlled trial of cimetidine for the treatment of nonulcer dyspepsia. ( Lance, P; Schiller, KF; Wastell, C, 1986) |
| "We randomly assigned 159 patients with non-ulcer dyspepsia, defined as chronic or recurrent epigastric pain without concomitant symptoms of the irritable bowel syndrome and with no evidence of organic disease, to treatment for three weeks with an antacid suspension one and three hours after meals, 400 mg of cimetidine twice a day, or placebo, according to a double-blind, double-dummy model." | 9.06 | Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. ( Adami, HO; Bates, S; Bergström, R; Gustavsson, S; Lööf, L; Nyberg, A; Nyrén, O, 1986) |
| "A double-blind, placebo-controlled trial was performed, using 400-mg cimetidine tablets or placebo twice daily for 4 weeks in 100 patients with non-ulcer dyspepsia (NUD) and erosive prepyloric changes (EPC) grade 2 or 3." | 9.05 | Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. ( Berstad, A; Nesland, AA, 1985) |
| "The symptomatic effect of cimetidine was examined in 27 patients with non-ulcer dyspepsia (NUD) by means of a multi-cross-over model (MCO model) for testing the symptomatic effect of drugs in individual patients." | 9.05 | The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. ( Fjøsne, U; Hafstad, PE; Johannessen, T; Kleveland, PM; Kristensen, P; Larsen, S; Løge, I; Petersen, H; Sandbakken, P; Sandvik, L, 1985) |
| "The effect of cimetidine (1 g daily) and placebo was studied in a controlled clinical trial comprising 50 patients with non-ulcer dyspepsia in whom an organic abnormality responsible for the dyspeptic symptoms was not disclosed by a standardized and extensive examination programme." | 9.05 | Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. ( Bonnevie, O; Eriksen, J; Kelbaek, H; Linde, J; Moesgaard, F; Mungaard, S, 1985) |
| "Fifty patients with active peptic ulcers on endoscopy were randomly allocated for treatment with placebo or cimetidine (1." | 9.05 | The relationship between active peptic ulcer, endoscopic duodenitis and symptomatic state after treatment with cimetidine. ( Danielsson, A; Ek, B; Nyhlin, H; Steen, L, 1980) |
| "Functional dyspepsia is a major diagnostic and therapeutic challenge for the clinician." | 6.67 | Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study. ( Brignoli, R; Halter, F; Miazza, B, 1994) |
| "Pirenzepine was not superior to placebo in decreasing symptoms." | 6.66 | Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. ( Hayden, A; McNeil, D; Piper, DW; Talley, NJ, 1986) |
| "To compare ecabet sodium and cimetidine in relieving symptoms of functional dyspepsia." | 5.12 | Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial. ( Choi, SR; Hahm, KB; Kim, JJ; Kim, N; Kim, SK; Lee, DH; Lee, EH; Lee, JH; Lee, ST; Park, JJ; Rhee, JC, 2006) |
| " Ulcer-like dyspepsia seemed to benefit from omeprazole." | 5.09 | A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome. ( Buskens, E; de Wit, NJ; Lewin van den Broek, NT; Numans, ME; Smout, AJ; Verheij, TJ, 2001) |
| "Before endoscopy a double-blind, randomized, controlled, single-subject trial comparing the symptomatic effect of 1-day treatment periods with cimetidine and placebo was conducted in patients with dyspepsia." | 5.07 | The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials. ( Dybdahl, J; Fosstvedt, D; Johannessen, T; Kleveland, PM; Kristensen, P; Løge, I; Petersen, H, 1991) |
| "Double-blind randomized controlled trials in single subjects (N of 1 RCTs) have demonstrated a beneficial symptomatic effect of cimetidine in reflux- or ulcer-like non-ulcer dyspepsia (NUD)." | 5.07 | Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. ( Dybdahl, J; Fosstvedt, D; Johannessen, T; Kleveland, PM; Kristensen, P; Løge, I; Petersen, H, 1992) |
| "A randomized double-blind antacid-controlled study was carried out to investigate the speed of onset of relief from dyspeptic pain with a novel, chewable formulation of cimetidine in 80 patients with persistent dyspepsia." | 5.06 | Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief? ( Parr, SN, 1989) |
| "The effect of cimetidine and placebo was examined in 123 patients with non-ulcer dyspepsia (NUD) by means of a 12-day multi-crossover model with 5 regular interchanges between cimetidine and placebo." | 5.06 | Cimetidine responders in non-ulcer dyspepsia. ( Fjøsne, U; Hafstad, PE; Halvorsen, T; Johannessen, T; Kleveland, PM; Kristensen, P; Løge, I; Petersen, H; Sandbakken, P, 1988) |
| "A randomized double-blind, placebo-controlled study was carried out in 56 patients with essential dyspepsia to investigate the therapeutic efficacy of cimetidine in providing symptomatic relief." | 5.06 | Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study. ( Broor, SL; Kumar, A; Singal, AK, 1989) |
| "We randomly assigned 159 patients with non-ulcer dyspepsia, defined as chronic or recurrent epigastric pain without concomitant symptoms of the irritable bowel syndrome and with no evidence of organic disease, to treatment for three weeks with an antacid suspension one and three hours after meals, 400 mg of cimetidine twice a day, or placebo, according to a double-blind, double-dummy model." | 5.06 | Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. ( Adami, HO; Bates, S; Bergström, R; Gustavsson, S; Lööf, L; Nyberg, A; Nyrén, O, 1986) |
| "Sixty patients with nonulcer dyspepsia took cimetidine 1 g daily or a placebo for 5 weeks in a double-blind trial." | 5.06 | A controlled trial of cimetidine for the treatment of nonulcer dyspepsia. ( Lance, P; Schiller, KF; Wastell, C, 1986) |
| "Patients with dyspepsia of unknown origin were randomly allocated to a controlled double-blind study to examine the symptomatic effect of cimetidine and antacid especially on the relief of pain, nausea, and bloating." | 5.06 | Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. ( Bodemar, G; Brodin, U; Gotthard, R; Jönsson, KA, 1988) |
| "Fifty patients with active peptic ulcers on endoscopy were randomly allocated for treatment with placebo or cimetidine (1." | 5.05 | The relationship between active peptic ulcer, endoscopic duodenitis and symptomatic state after treatment with cimetidine. ( Danielsson, A; Ek, B; Nyhlin, H; Steen, L, 1980) |
| "The symptomatic effect of cimetidine was examined in 27 patients with non-ulcer dyspepsia (NUD) by means of a multi-cross-over model (MCO model) for testing the symptomatic effect of drugs in individual patients." | 5.05 | The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. ( Fjøsne, U; Hafstad, PE; Johannessen, T; Kleveland, PM; Kristensen, P; Larsen, S; Løge, I; Petersen, H; Sandbakken, P; Sandvik, L, 1985) |
| "The effect of cimetidine (1 g daily) and placebo was studied in a controlled clinical trial comprising 50 patients with non-ulcer dyspepsia in whom an organic abnormality responsible for the dyspeptic symptoms was not disclosed by a standardized and extensive examination programme." | 5.05 | Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. ( Bonnevie, O; Eriksen, J; Kelbaek, H; Linde, J; Moesgaard, F; Mungaard, S, 1985) |
| "A double-blind, placebo-controlled trial was performed, using 400-mg cimetidine tablets or placebo twice daily for 4 weeks in 100 patients with non-ulcer dyspepsia (NUD) and erosive prepyloric changes (EPC) grade 2 or 3." | 5.05 | Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. ( Berstad, A; Nesland, AA, 1985) |
| "Based on these data both treatments are significantly more effective than placebo in the symptomatic treatment of non-ulcer dyspepsia, with gastroprokinetics (cisapride, domperidone) being more effective than histamine H2-receptor antagonists (cimetidine, ranitidine)." | 4.81 | Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. ( Allescher, HD; Böckenhoff, A; Hartung, J; Knapp, G; Wienbeck, M, 2001) |
| "A theoretical investigation was carried out to determine whether the use of an antibody test for Helicobacter pylori (HP) and the use of bismuth oxide with optional antibiotics, would be cost effective in the diagnosis and treatment of patients with dyspepsia." | 3.68 | [Costs and effectiveness of diagnosis and treatment of patients with dyspepsia, determined with the aid of a computer model]. ( Loffeld, RJ; Rutten, FF; Schipper, CK, 1993) |
| " The advantages of the single case approach and the impact of the MCOM is illustrated by the results from a study of the effect of cimetidine in non ulcer dyspepsia." | 3.67 | Experience with a multi crossover model in dyspepsia. ( Fosstvedt, D; Johannessen, T; Petersen, H, 1988) |
| " pylori eradication (which was possible in 84% of the patients), at the end of the 1-year study period, on an intention to treat basis 62% of the patients could either stop or significantly reduce dosage of their H2RA." | 2.70 | Helicobacter pylori eradication in patients on long-term H2 receptor antagonists. Economic and symptomatic benefits. A large prospective study in primary care. ( Giaffer, MH; Verma, S, 2002) |
| "Functional dyspepsia is a major diagnostic and therapeutic challenge for the clinician." | 2.67 | Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study. ( Brignoli, R; Halter, F; Miazza, B, 1994) |
| "Pirenzepine was not superior to placebo in decreasing symptoms." | 2.66 | Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. ( Hayden, A; McNeil, D; Piper, DW; Talley, NJ, 1986) |
| "Cimetidine treatment resulted in a significant increase in plasma testosterone levels which was not found in the ranitidine group." | 2.66 | A comparative study of the effects of ranitidine and cimetidine on carbohydrate tolerance, growth hormone secretion and the hypothalamic-pituitary-gonadal axis in man. ( Amphlett, G; Barnes, GD; Hoad, J; Lowry, C; Riley, AJ; Saunders, J; Scobie, IN; Sonksen, PH; Wheeler, MJ, 1986) |
| "Acute hypocalcemia is generally caused by a sudden drop in serum calcium ion and presents with a mild or severe form of tetany." | 1.91 | Hypocalcemic tetany associated with simultaneous administration of cimetidine and nifedipine: a case report. ( Bezabhe, WM; Bezabih, YM; Bimrew, MA, 2023) |
| " To examine the potential for drug-drug interactions at these two transporters, the pharmacokinetics of gabapentin enacarbil were evaluated in healthy adults after administration alone or in combination with either naproxen (an MCT-1 substrate) or cimetidine (an OCT2 substrate)." | 1.36 | Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine. ( Blumenthal, R; Cundy, KC; Ho, J; Lal, R; Luo, W; Sukbuntherng, J; Vicente, V, 2010) |
| "Cimetidine was found to have no effect on the histological features of chronic/acute inflammation and erosion." | 1.27 | Histological findings in erosive prepyloric changes. ( Berstad, A; Nesland, AA; Serck-Hanssen, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (68.97) | 18.7374 |
| 1990's | 10 (17.24) | 18.2507 |
| 2000's | 6 (10.34) | 29.6817 |
| 2010's | 1 (1.72) | 24.3611 |
| 2020's | 1 (1.72) | 2.80 |
| Authors | Studies |
|---|---|
| Bezabih, YM | 1 |
| Bimrew, MA | 1 |
| Bezabhe, WM | 1 |
| Lal, R | 1 |
| Sukbuntherng, J | 1 |
| Luo, W | 1 |
| Vicente, V | 1 |
| Blumenthal, R | 1 |
| Ho, J | 1 |
| Cundy, KC | 1 |
| Lee, JH | 2 |
| Kim, JJ | 1 |
| Hahm, KB | 1 |
| Lee, DH | 1 |
| Kim, N | 1 |
| Kim, SK | 1 |
| Park, JJ | 1 |
| Choi, SR | 1 |
| Lee, ST | 1 |
| Lee, EH | 1 |
| Rhee, JC | 1 |
| Sakamoto, C | 1 |
| Ogoshi, K | 1 |
| Saigenji, K | 1 |
| Narisawa, R | 1 |
| Nagura, H | 1 |
| Mine, T | 1 |
| Tada, M | 1 |
| Umegaki, E | 1 |
| Maekawa, T | 1 |
| Maekawa, R | 1 |
| Maeda, K | 1 |
| Reed, PI | 1 |
| Smith, PL | 1 |
| Haines, K | 1 |
| House, FR | 1 |
| Walters, CL | 1 |
| Gray, GR | 2 |
| McWhinnie, D | 1 |
| Smith, IS | 2 |
| Gillespie, G | 2 |
| Schiller, KF | 2 |
| Bendtsen, F | 2 |
| Danø, P | 2 |
| Guldhammer, B | 2 |
| Remvig, L | 2 |
| Krogsøe, O | 1 |
| Kang, JY | 1 |
| Ng, SK | 1 |
| Guan, R | 1 |
| Kaye, WA | 1 |
| Passero, MA | 1 |
| Solomon, RJ | 1 |
| Johnson, LA | 1 |
| Thomson, AB | 1 |
| Brust, R | 1 |
| Dwyer, JM | 1 |
| Wensel, R | 1 |
| Sherbaniuk, R | 1 |
| Walker, K | 1 |
| Barbezat, GO | 1 |
| Marks, IN | 1 |
| Wright, JP | 1 |
| Denyer, M | 1 |
| Garisch, JA | 1 |
| Lucke, W | 1 |
| Danielsson, A | 1 |
| Ek, B | 1 |
| Nyhlin, H | 1 |
| Steen, L | 1 |
| Halter, F | 1 |
| Miazza, B | 1 |
| Brignoli, R | 1 |
| Saha, N | 1 |
| Sachdev, A | 1 |
| Bhasin, DK | 1 |
| Sankaranahyanan, A | 1 |
| Khosla, PP | 1 |
| Singh, K | 1 |
| Sharma, PL | 1 |
| Schipper, CK | 1 |
| Rutten, FF | 1 |
| Loffeld, RJ | 1 |
| Trimble, I | 1 |
| Derrett, C | 1 |
| Lamers, CB | 1 |
| Lewin van den Broek, NT | 1 |
| Numans, ME | 1 |
| Buskens, E | 1 |
| Verheij, TJ | 1 |
| de Wit, NJ | 1 |
| Smout, AJ | 1 |
| Allescher, HD | 1 |
| Böckenhoff, A | 1 |
| Knapp, G | 1 |
| Wienbeck, M | 1 |
| Hartung, J | 1 |
| Redstone, HA | 1 |
| Barrowman, N | 1 |
| Veldhuyzen Van Zanten, SJ | 1 |
| Verma, S | 1 |
| Giaffer, MH | 1 |
| Mullen, PW | 1 |
| Mackenzie, I | 1 |
| Campa, PP | 1 |
| Tomassini, T | 1 |
| De Curtis, G | 1 |
| Attili, AF | 1 |
| Shearman, DJ | 1 |
| Johannessen, T | 8 |
| Petersen, H | 7 |
| Kristensen, P | 7 |
| Fosstvedt, D | 3 |
| Kleveland, PM | 7 |
| Dybdahl, J | 2 |
| Løge, I | 7 |
| Singh, S | 1 |
| Singh, N | 1 |
| Kochhar, R | 1 |
| Talwar, P | 1 |
| Mehta, SK | 1 |
| Jensen, SL | 1 |
| Funch Jensen, P | 1 |
| Singal, AK | 1 |
| Kumar, A | 1 |
| Broor, SL | 1 |
| Jönsson, KA | 2 |
| Gotthard, R | 2 |
| Bodemar, G | 2 |
| Brodin, U | 2 |
| Parr, SN | 1 |
| Hernandez Avila, M | 1 |
| Walker, AM | 1 |
| Romieu, I | 1 |
| Spiegelman, DL | 1 |
| Perera, DR | 1 |
| Jick, H | 1 |
| Rokkas, T | 1 |
| Sladen, GE | 1 |
| Zuberi, SJ | 1 |
| Qureshi, H | 1 |
| Banatwala, NS | 1 |
| Rehman, R | 1 |
| Alam, E | 1 |
| Fjøsne, U | 5 |
| Halvorsen, T | 2 |
| Hafstad, PE | 5 |
| Sandbakken, P | 5 |
| Berstad, A | 3 |
| Nesland, A | 1 |
| Nyrén, O | 1 |
| Adami, HO | 1 |
| Bates, S | 1 |
| Bergström, R | 1 |
| Gustavsson, S | 1 |
| Lööf, L | 1 |
| Nyberg, A | 1 |
| Talley, NJ | 1 |
| McNeil, D | 1 |
| Hayden, A | 1 |
| Piper, DW | 1 |
| Rappaport, BS | 1 |
| Lance, P | 1 |
| Wastell, C | 1 |
| Scobie, IN | 1 |
| Saunders, J | 1 |
| Barnes, GD | 1 |
| Hoad, J | 1 |
| Wheeler, MJ | 1 |
| Lowry, C | 1 |
| Sonksen, PH | 1 |
| Amphlett, G | 1 |
| Riley, AJ | 1 |
| Nesland, AA | 2 |
| Serck-Hanssen, A | 1 |
| Larsen, S | 3 |
| Sandvik, L | 3 |
| Kelbaek, H | 1 |
| Linde, J | 1 |
| Eriksen, J | 1 |
| Mungaard, S | 1 |
| Moesgaard, F | 1 |
| Bonnevie, O | 1 |
| Johannesen, T | 1 |
| Pettersen, H | 1 |
6 reviews available for cimetidine and Dyspepsia
| Article | Year |
|---|---|
[25 years of gastric acid blockers].
Topics: Anti-Ulcer Agents; Cimetidine; Dyspepsia; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; | 1999 |
Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies.
Topics: Cimetidine; Cisapride; Domperidone; Dyspepsia; Gastrointestinal Agents; Histamine H2 Antagonists; Hu | 2001 |
H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.
Topics: Cimetidine; Dyspepsia; Histamine H2 Antagonists; Humans; Pain; Randomized Controlled Trials as Topic | 2001 |
Role of sucralfate in peptic disease.
Topics: Cimetidine; Dyspepsia; Esophagitis, Peptic; Gastritis; Humans; Peptic Ulcer; Ranitidine; Recurrence; | 1992 |
The clinical relevance of endoscopic and histologic inflammation of gastroduodenal mucosa in dyspepsia of unknown origin.
Topics: Adult; Antacids; Cimetidine; Duodenitis; Duodenoscopy; Dyspepsia; Female; Gastric Acid; Gastric Muco | 1989 |
Bismuth: effects on gastritis and peptic ulcer.
Topics: Cimetidine; Duodenal Ulcer; Dyspepsia; Gastritis; Humans; Organometallic Compounds; Peptic Ulcer; Re | 1988 |
31 trials available for cimetidine and Dyspepsia
| Article | Year |
|---|---|
Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial.
Topics: Abietanes; Adult; Age Factors; Anti-Ulcer Agents; Cimetidine; Double-Blind Method; Dyspepsia; Female | 2006 |
Comparison of the effectiveness of geranylgeranylacetone with cimetidine in gastritis patients with dyspeptic symptoms and gastric lesions: a randomized, double-blind trial in Japan.
Topics: Anti-Ulcer Agents; Cimetidine; Diterpenes; Double-Blind Method; Dyspepsia; Female; Gastritis; Gastro | 2007 |
Five-year study of cimetidine or surgery for severe duodenal ulcer dyspepsia.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Dyspepsia; Female; Follow | 1982 |
[Cimetidine therapy in radio-negative dyspepsia].
Topics: Adolescent; Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Female; Hum | 1983 |
[The histological picture of the gastric and duodenal mucosa in X-ray negative dyspepsia. Before and after treatment with cimetidine].
Topics: Adolescent; Adult; Cimetidine; Duodenum; Dyspepsia; Female; Gastric Mucosa; Humans; Intestinal Mucos | 1984 |
Comparison of sucralfate with cimetidine in the short-term treatment of chronic peptic ulcers.
Topics: Adult; Aluminum; Antacids; Cimetidine; Clinical Trials as Topic; Disaccharides; Drug Evaluation; Duo | 1980 |
The relationship between active peptic ulcer, endoscopic duodenitis and symptomatic state after treatment with cimetidine.
Topics: Adolescent; Adult; Cimetidine; Clinical Trials as Topic; Creatinine; Double-Blind Method; Duodenitis | 1980 |
Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study.
Topics: Adult; Cimetidine; Cisapride; Double-Blind Method; Dyspepsia; Female; Humans; Male; Piperidines; Tre | 1994 |
Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Topics: Adult; Cimetidine; Drug Hypersensitivity; Dyspepsia; Famotidine; Female; Histamine; Histamine H2 Ant | 1993 |
A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome.
Topics: Anti-Ulcer Agents; Cimetidine; Cisapride; Clinical Protocols; Dyspepsia; Endoscopy, Gastrointestinal | 2001 |
Helicobacter pylori eradication in patients on long-term H2 receptor antagonists. Economic and symptomatic benefits. A large prospective study in primary care.
Topics: Cimetidine; Cost Savings; Dyspepsia; Female; Follow-Up Studies; Gastric Acid; Gastritis; Helicobacte | 2002 |
Long term cimetidine in the management of severe duodenal ulcer dyspepsia.
Topics: Adult; Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; D | 1978 |
Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials.
Topics: Adult; Aged; Cimetidine; Confidence Intervals; Double-Blind Method; Dyspepsia; Esophagitis; Humans; | 1992 |
The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials.
Topics: Adult; Age Factors; Cimetidine; Double-Blind Method; Dyspepsia; Endoscopy, Gastrointestinal; Esophag | 1991 |
Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Femal | 1989 |
The clinical relevance of endoscopic and histologic inflammation of gastroduodenal mucosa in dyspepsia of unknown origin.
Topics: Adult; Antacids; Cimetidine; Duodenitis; Duodenoscopy; Dyspepsia; Female; Gastric Acid; Gastric Muco | 1989 |
Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?
Topics: Administration, Oral; Adult; Aged; Antacids; Cimetidine; Double-Blind Method; Dyspepsia; Female; Hum | 1989 |
Lack of therapeutic effect of cimetidine in non-ulcer dyspepsia.
Topics: Adolescent; Adult; Cimetidine; Clinical Trials as Topic; Dyspepsia; Female; Humans; Male; Middle Age | 1988 |
Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin.
Topics: Adolescent; Adult; Aged; Antacids; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Dyspep | 1988 |
Cimetidine responders in non-ulcer dyspepsia.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Dyspepsia; Female; Humans; Male; Middle Aged | 1988 |
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Topics: Adolescent; Adult; Antacids; Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Met | 1986 |
Cimetidine and non-ulcer dyspepsia.
Topics: Cimetidine; Clinical Trials as Topic; Dyspepsia; Humans | 1986 |
Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia.
Topics: Adult; Aged; Benzodiazepinones; Cimetidine; Clinical Trials as Topic; Dyspepsia; Female; Humans; Mal | 1986 |
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Topics: Antacids; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Humans; Random Alloc | 1986 |
A controlled trial of cimetidine for the treatment of nonulcer dyspepsia.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenitis; Dyspepsia; Female; Hum | 1986 |
A comparative study of the effects of ranitidine and cimetidine on carbohydrate tolerance, growth hormone secretion and the hypothalamic-pituitary-gonadal axis in man.
Topics: Adult; Blood Glucose; Cimetidine; Dyspepsia; Glucose Tolerance Test; Gonadal Steroid Hormones; Growt | 1986 |
The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Dyspepsia; Female; Humans; Male; Middle Aged; Pla | 1985 |
Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Femal | 1985 |
Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Female; Gastric Mucosa; | 1985 |
Controlled trials in gastrodyspepsia: a methodological aspect.
Topics: Cimetidine; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Dyspepsia; Huma | 1985 |
[Cimetidine in non-ulcer dyspepsia. Preliminary results with a multi-crossover model].
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Dyspepsia; Female; Humans; Male; Middle Aged; Pep | 1985 |
22 other studies available for cimetidine and Dyspepsia
| Article | Year |
|---|---|
Hypocalcemic tetany associated with simultaneous administration of cimetidine and nifedipine: a case report.
Topics: Calcium Gluconate; Cimetidine; Dyspepsia; Female; Humans; Hypocalcemia; Middle Aged; Nifedipine; Spa | 2023 |
Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine.
Topics: Adolescent; Adult; Biological Transport; Carbamates; Cimetidine; Constipation; Dose-Response Relatio | 2010 |
Effect of cimetidine on gastric juice N-nitrosamine concentration.
Topics: Achlorhydria; Adolescent; Adult; Aged; Bacteria; Cimetidine; Digestive System; Dyspepsia; Fasting; F | 1981 |
Cimetidine for dyspepsia?
Topics: Cimetidine; Dyspepsia; Humans | 1984 |
The use of one gram daily cimetidine in the treatment of peptic ulcer in Singapore.
Topics: Adult; Aged; Cimetidine; Drug Evaluation; Duodenal Ulcer; Dyspepsia; Female; Humans; Male; Middle Ag | 1983 |
Cimetidine-induced interstitial nephritis with response to prednisone therapy.
Topics: Acute Disease; Aged; Cimetidine; Dyspepsia; Female; Guanidines; Humans; Nephritis, Interstitial; Pre | 1983 |
Cimetidine for recurrent ulcer after gastric surgery.
Topics: Adult; Aged; Cimetidine; Dyspepsia; Female; Follow-Up Studies; Gastrectomy; Gastrins; Gastroscopy; G | 1983 |
The treatment of peptic ulcer.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Diagnosis, Differential; Dyspepsia; Humans; Organometallic C | 1982 |
[Costs and effectiveness of diagnosis and treatment of patients with dyspepsia, determined with the aid of a computer model].
Topics: Bismuth; Cimetidine; Clinical Protocols; Computer Simulation; Cost-Benefit Analysis; Drug Therapy, C | 1993 |
Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Studies'assumptions are removed from clinical practice.
Topics: Anti-Ulcer Agents; Cimetidine; Drug Costs; Dyspepsia; Endoscopy, Gastrointestinal; Helicobacter Infe | 1996 |
Gastric cancer in patients who have taken cimetidine.
Topics: Cimetidine; Dyspepsia; Guanidines; Humans; Stomach Neoplasms | 1979 |
[Effect of cimetidine on gastric secretion in the interdigestive phase and after pentagastrin stimulation in patients with dyspepsia].
Topics: Adult; Cimetidine; Dyspepsia; Female; Gastric Acidity Determination; Gastric Juice; Guanidines; Huma | 1978 |
The treatment of dyspepsia.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Dyspepsia; Esophagitis; Humans; Metoclopramide; Parasy | 1977 |
Cimetidine therapy and duodenal candidiasis: role in healing process.
Topics: Candidiasis; Cimetidine; Colony Count, Microbial; Duodenal Diseases; Duodenal Ulcer; Dyspepsia; Fema | 1992 |
Controlled trials in single subjects. 1. Value in clinical medicine.
Topics: Cimetidine; Dyspepsia; Humans; Patient Compliance; Physician-Patient Relations; Placebo Effect; Rand | 1991 |
Non-ulcer dyspepsia.
Topics: Cimetidine; Dyspepsia; Gastric Mucosa; Humans | 1986 |
Management of dyspepsia: report of a working party.
Topics: Adult; Antacids; Bismuth; Cimetidine; Diagnosis, Differential; Domperidone; Dyspepsia; Histamine H2 | 1988 |
Choice of non-steroidal anti-inflammatory drug in persons treated for dyspepsia.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics; Antacids; Anti-Inflammatory Agents, Non-Steroida | 1988 |
Experience with a multi crossover model in dyspepsia.
Topics: Cimetidine; Clinical Trials as Topic; Data Interpretation, Statistical; Dyspepsia; Humans; Medical R | 1988 |
Dyspepsia: Therapeutic response as a diagnostic tool.
Topics: Cimetidine; Dyspepsia; Gastric Acid; Humans; Pilot Projects | 1987 |
Erosive prepyloric changes (EPC)--a new entity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cimetidine; Double-Blind Method; Dyspepsia; Gastr | 1987 |
Histological findings in erosive prepyloric changes.
Topics: Biopsy; Cimetidine; Dyspepsia; Endoscopy; Gastric Mucosa; Humans; Inflammation; Pylorus | 1986 |